Conferences Papers

2019

  • Hang T. Ta. Advancing the Diagnosis and Treatment of Cardiovascular Diseases with Nanotechnology, invited lecture, CRS Drug Delivery Australia 2019 Conference, 18-19 November 2019.
  • Hang T. Ta. Advancing the Diagnosis and Treatment of Cardiovascular Diseases with Nanotechnology, oral presentation, 2019 Australian Society of Molecular Imaging Conference, 7-8 November 2019, Adelaide, Australia.
  • Hang T. Ta. Advancing the Diagnosis and Treatment of Cardiovascular Diseases with Nanotechnology, invited talk, 2019 Australian Vascular Biology Society Scientific Meeting, 19-22 September 2019, Sydney, Australia.
  • Hang T. Ta. Iron oxide based Nanoparticles and Polymeric 19F Nanomaterials for Molecular Magnetic Resonance Imaging, invited lecture, invited lecture, International Conference on Pure and Applied Chemistry and International Symposium on Applied Polymeric Materials, 6 – 9 August, 2019, Yangon, Myanmar.
  • Hang T. Ta. Iron oxide based Nanoparticles and Polymeric 19F Nanomaterials for Molecular Magnetic Resonance Imaging, invited lecture, Vietnam Young Academy International Conference on Nanomaterials for Healthcare, 29 – 31 July 2019, Da Nang, Vietnam.
  • Hang T Ta. Activatable Gadolinium-Iron Oxide Nanoparticles for Detection and Discrimination of Thrombosis, oral presentation, 87th European Atherosclerosis Society Congress, 26-29 May, 2019, Maastricht, The Netherlands.

2018

  • Hang T. Ta. Iron oxide based nanomaterials for advanced diagnosis and treatment of cardiovascular diseases, invited lecture, 3rd International Conference on Emerging Advanced Nanomaterials (ICEAN), 30 October – 2 November 2018, Newcastle, Australia.
  • Hang T. Ta. Cleavable Gadolinium-Iron Oxide Nanoparticles for Detection and Discrimination of  Thrombosis, World Molecular Imaging Congress 2018, 12-15 September 2018, Seattle, USA.
  • Hang T. Ta. Novel bionano-solutions for diagnosis and treatment of cardiovascular disease, invited presentation, the 7th International Conference in Vietnam on the Development of Biomedical Engineering, 27-29 June 2018, Ho Chi Minh City, Vietnam.
  • Hang T. Ta, Nina Arndt, Yuao Wu, Hui J. Lim. Shea Landeen, Run hang, Danielle Kamato, Peter Little, Andrew K. Whittaker, Zhi Ping Xu. Activatable Gadolinium-Iron Oxide Nanoparticles for Detection and Discrimincation of Thrombosis, oral presentation, 9th International Nanomedicine Conference, 25-27 June 2018, Sydney, Australia.
  • Hang T. Ta. Activatable Magnetic Resonance Nanosensor as a Potential Imaging Agent for Detecting and Discriminating Thrombosis, late-breaking poster, XVIIII International Symposium on Atherosclerosis, 9 – 12 June 2018, Toronto, Canada.
  • Hang T. Ta, Yuao Wu, Gary Cowin, Gordon Xu, Xiaowei Wang, Peter Little, Christoph Hagemeyer, Karlheinz Peter, Andrew Whittaker. Novel nanomaterials based on metal and metal oxide for advanced diagnosis and treatment of cardiovascular disease, oral presentation (finalist), Joint Annual Scientific Meeting of AAS, HBPRCA and AVBS 2018, Adelaide, Australia, 27-30 November 2018.
  • Hang T. Ta. Iron oxide based nanomaterials for diagnosis and treatment of cardiovascular disease, oral presentation, 2018 Australian Society of Molecular Imaging Conference, Perth, Australia, 20-21 November 2018.

2017

  • Hang T. Ta, Zhen Li, Christoph Hagemeyer, Yuao Wu, Hui Jean Lim, Ninan Arndt, Gary Cowin, Karlheinz Peter, Andrew Whittaker, Gordon Xu. Novel bionano-solutions for diagnosis and treatment of cardiovascular disease, oral presentation, 2017 International Conference on BioNano Innovation (ICBNI), 24-27 September 2017, Brisbane, Australia.
  • Hang T. Ta. Novel bionanotechnological solutions for diagnosis and treatment of cardiovascular disease, invited presentation, 25th Polychar: World Forum on Advanced Materials, 9-13 October 2017, Kuala Lumpur, Malaysia.
  • Hui Jean Lim, Jian Wei, Wei Wang, Andrew Whittaker, Zhi Ping Xu, Hang T. Ta*. Activatavle Magnetic Resonance Imaging Nano-sensors for Advanced Diagnostics of Cardiovascular Disease, oral presentation, World Molecular Imaging Congress, Philadelphia, USA, 13-16 September 2017.
  • Hang T. Ta*, Zhen Li, Christoph Hagemeyer, Gary Cowin, Jathushan Palasubramaniam, Xiaowei Wang, Karen Alt, Karlheinz Peter, Andrew Whittaker. Detection of vascular thrombosis via molecular magnetic resonance imaging using dual positive and negative contrast agents, World Molecular Imaging Congress, Philadelphia, USA, 13-16 September 2017.
  • Hang T. Ta*. Novel biotechnology solutions for diagnosis and treatment of cardiovascular disease, invited lecture, International Congress and Expo on Cardiology, Miami, USA, 11-13 September 2017.
  • Hang T. Ta. Novel Bionanotechnological Solutions Based On Metal Oxide And Metal To Preserve And Assess Organs For Transplantation, invited presentation, Organ Banking Summit, Boston, USA, 3-6 August, 2017
  • Hui Jean Lim, Jian Wei, Wei Wang, Gary Cowin, Andrew Whittaker, Hang Thu Ta*. Thrombin-Activatable Magnetic Resonance Imaging Nano-sensors for Advanced Diagnositcs of Cardiovascular Disease, oral presentation, The 15th International Conference on Advanced Materials, Kyoto, Japan, 27 August – 1 September 2017.
  • Hang T. Ta, Zhen Li, Christoph Hagemeyer, Gary Cowin, Nyoman Kurniawan, Jathushan Palasubramaniam, Xiaowei Wang, Karen Alt, Karlheinz Peter, Andrew Whittaker. Ultra-small Iron Oxide Nanoparticles for Molecular Imaging of Activated Platelets Displaying Unique Dual MRI Contrast. 12th European Molecular Imaging Meeting, Cologne, Germany, 5-7 April, 2017.
  • Hang T. Ta, Zhen Li, Christoph Hagemeyer, Gary Cowin, Nyoman Kurniawan, Jathushan Palasubramaniam, Karlheinz Peter, Andrew Whittaker. Self-Confirming Molecular Imaging of Activated Platelets via Iron Oxide Nanoparticles Displaying Unique Dual MRI Contrast. 85th European Atherosclerosis Society Congress, Prague, Czech Republic, 23-26 April, 2017.
  • Hang T. Ta, Zhen Li, Karlheinz Peter, Christoph E. Hagemeyer, Gary Cowin, Nyoman Kurniawan, Andrew K. Whittaker. Development of Ultra-small Dual-Contrast Iron Oxide Nanoparticle for Molecular Imaging of Cardiovascular Diseases, oral presentation, The 8th Biennial Australian Colloid and Interface Symposium (ACIS), Coffs Harbour, Australia, 29 January – 2 February 2017.

2016

  • Hang T. Ta, Ephraem Leitner, Fu Jia, Katherine Putnam, Dominik von Elverfeldt, Karlheinz Peter, Christoph Hagemeyer. Targeting Imaging Contrast Agents and Live Cells in Cardiovascular Disease via a Chemo-Biotechnological Approach, oral presentation, the 17th International Biotechnology Symposium and Exhibition, Melbourne, Australia, 24-27 October, 2016.
  • Hang T. Ta, Zhen Li, Christoph Hagemeyer, Karlheinz Peter, Andrew Whittaker. Ultra-small positive and negative dual contrast iron oxide nanoparticles for molecular imaging of cardiovascular disease, oral presentation, 84th European Atherosclerosis Society Congress, Innsbruck, Austria, 29 May – 1 June 2016.
  • Hang T. Ta, Zhen Li, Karlheinz Peter, Christoph E. Hagemeyer, Gary Cowin, Nyoman Kurniawan, Andrew K. Whittaker. Molecular Imaging of Cardiovascular Disease Using Dual Contrast Iron Oxide Nanoparticles, Joint Annual Scientific Meeting of AAS, HBPRCA, and AVBS, Hobart, Australia, 7-10 December 2016.
  • Hang T. Ta, Zhen Li, Christoph Hagemeyer, Gary Cowin, Nyoman Kurniawan, Karlheinz Peter, Andrew Whittaker. Toward Better Diagnosis for Cardiovascular Disease: Molecular Imaging via Dual Contrast Iron Oxide Nanoparticles, oral presentation, Cardiovascular Research Showcase Event, Brisbane, Australia, 22 November 2016.
  • Hang T. Ta, Zhen Li, Christoph Hagemeyer, Karlheinz Peter, Andrew Whittaker. Dual contrast iron oxide nanoparticle as a potential contrast agent for molecular imaging of cardiovascular disease, oral presentation, 2016 International Nanomedicine Conference, Sydney, Australia, 27-29 June 2016.

2015-2010

  • Hang T. Ta; Sandeep Prabhu; Ephraem Leitner; Fu Jia; D. von Elverfeldt; K. Putnam; T. Heidt; A. Nair; H. Pearce; C. von zur Muhlen; X. Wang; K. Peter; C.E. Hagemeyer. Targeted molecular imaging and cell homing in cardiovascular disease via antibody-sortagging, oral presentation, 83rd European Atherosclerosis Society Congress, Glasgow, United Kingdom, 22-25 March 2015.
  • Hang T. Ta, Zhen Li, Ephraem Leitner, Fu Jia, Karlheinz Peter, Christoph Hagemeyer, Andrew Whittaker. The development of targeted multimodal iron oxide particles for imaging of cardiovascular disease: A marriage between chemistry and biology, oral presentation, 7th Asian Biological Inorganic Chemistry Conference, Gold Coast, Queensland, 30 November – 5 December 2014.
  • Hang T. Ta, Ephraem Leitner, Fu Jia, Ashish Nair, Karlheinz Peter, Christoph E. Hagemeyer. A Universal Approach to Targeted Cell Delivery in Cardiovascular Disease, NanoBio Australia 2014, Brisbane, Queensland, 7-10 July 2014.
  • Hang T. Ta, Ephraem Leitner, Fu Jia, Karlheinz Peter, Christoph Hagemeyer. Functionalization of MR and CT Agents for Atherothrombosis Imaging, Australian Vascular Biology Society 20th Annual Scientific Meeting, Gold Coast, Queensland, 13-16 September 2012.
  • Hang T. Ta, Prabhu S, Leitner E, Jia F, Putnam K, Bassler N, Peter K, Hagemeyer CE. A Novel Chemo-Enzymatic Approach For Targeted Delivery Of Contrast Imaging Agents And Stem Cells In Cardiovascular Disease, oral presentation, National Heart Foundation Conference 2011, Melbourne, Victoria, 17-19 March 2011.
  • Ta HT, Leitner E, Jia F, Peter K, Hagemeyer CE. Synthesis and Functionalization of Contrast Particles for Molecular Imaging of Atherosclerosis, poster presentation, European Molecular Imaging Meeting 2011, Leiden, The Netherland, 19-21 June 2011.
  • Ta HT, Prabhu S, Leitner E, Jia F, Putnam K, Bassler N, Peter K, Hagemeyer CE. Antibody-Sortagging: A Universal Approach Towards Targeted Molecular Imaging And Cell Homing In Cardiovascular Disease, late-breaking basic science poster presentation, American Heart Association Scientific Sessions 2010, Chicago, Illinois, America, 13-17 November 2010.
  • Hang T. Ta, Prabhu S, Leitner E, Jia F, Putnam K, Bassler N, Peter K, Hagemeyer CE. Particle and cell targeting to atherothrombosis via Sortase A coupling, oral presentation (top 3 abstracts), Australian Vascular Biology Society (AVBS) Annual Scientific Meeting 2010, Lorne, Victoria, 16-19 September 2010.
  • Hang T. Ta, Prabhu S, Leitner E, Jia F, Putnam K, Bassler N, Peter K, Hagemeyer CE. A novel biotechnological approach for targeted regenerative cell therapy and molecular imaging of atherothrombosis, oral presentation, 58th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ Annual Scientific Meeting 2010), Adelaide, 5-8 August 2010.

2009-2002

  • CR Dass,  HT Ta, ML Tan, LM Khachigian, I Larson, DE Dunstan, PF Choong. Chitosan-based systems for cancer chemo-gene-therapy, oral presentation, 21st Lorne Cancer Conference, Melbourne, 12-14 February 2009.   
  • Hang T. Ta, Crispin R. Dass, Ian Larson, Peter Choong, Dave Dunstan. A drug delivery hydrogen system for osteosarcoma chemo-gene therapy, poster presentation, The Melbourne Engineering Research Institute (MERIT) Symposium 08, Melbourne, 2 October 2008 (Poster Award for Innovative Health-related Research).
  • Hang Thu Ta, Crispin R. Dass, Dave E. Dunstan. Thermosenstive & pH-dependant chitosan/orthophosphate hydrogel delivery system, poster presentation, Nanomedicine and Drug Delivery Symposium 07, Boston, USA, 2-3 November 2007.
  • Hang Thu Ta, Dave E. Dunstan. Thermo-sensitive chitosan/orthophosphate gel system, 25th Australian Colloid & Surface Science Student Conference, Victoria, February 2006.
  • Hang Thu Ta, Nga Thanh Nguyen, Luong Duc Nguyen, Huyen Thi Phan. 2002. Applications of papain in food industry and medical field (in Vietnamese). Paper presented at 8th National Science and Technology Conference, Vietnam, 26- 29 April 2002.